Innovating for the Future of Pet Health
Innovating for the Future of Pet Health
Changqi Biotech – Empowering veterinarians and pet owners with lab-grade accuracy and
speed through advanced isothermal amplification technology.
Pioneering Molecular Diagnostics
Pioneering Molecular Diagnostics
Changqi Biotech was founded by elite scientists from Harvard University and Shanghai Jiao Tong University. Since launching R&D in 2020, we have dedicated ourselves to revolutionizing molecular diagnostics. We developed China's first fully automated, ultra-multiplex microfluidic system based on isothermal amplification. Our mission is to act as a "Home Veterinary Guardian," making lab-grade testing accessible and fast (5-15 mins) for everyone.
Elite R&D: Led by Harvard & SJTU researchers
Rapid Tech: Results in 5-15 minutes.
Vertical Supply: In-house reagents & device production.
Closed-Loop: Partnered with JD Health & New Ruipeng.
Elite R&D Strength
Elite R&D Strength
Driven by a multidisciplinary team of experts since 2020, we are dedicated to overcoming the toughest challenges in molecular diagnostics.
Academic Leadership
Spearheaded by postdoctoral researchers from Harvard University and doctoral supervisors from Shanghai Jiao Tong University, ensuring top-tier scientific rigor.
Multidisciplinary Synergy
Pioneering Innovation
A unique fusion of clinical medicine, molecular biology, and microfluidic engineering. We bridge the gap between complex lab protocols and simple home use.
We developed China's first fully automated isothermal microfluidic system, filling a critical market gap with 100% proprietary intellectual property.
2020
2020
5-15
5-15
100%
100%
1-10
1-10
R&D Inception
R&D Inception
Minutes Result
Minutes Result
Self-Developed
Self-Developed
Copies Sensitivity
Copies Sensitivity
Dedicated to molecular diagnostics innovation since March 2020, driven by elite scientists.
Dedicated to molecular diagnostics innovation since March 2020, driven by elite scientists.
World's fastest isothermal amplification. Lab-grade accuracy in just minutes, not hours.
World's fastest isothermal amplification. Lab-grade accuracy in just minutes, not hours.
Full control over core raw materials, enzymes, and device manufacturing for max quality.
Full control over core raw materials, enzymes, and device manufacturing for max quality.
Ultra-high sensitivity capable of detecting trace pathogens at the molecular level.
Ultra-high sensitivity capable of detecting trace pathogens at the molecular level.
Our Milestones
Started developing core isothermal amplification and microfluidic tech for rapid diagnostics.
June 2024: Official Establishment
Officially established Changqi Biotech (Suzhou) to lead the commercialization of our tech.
Oct 2024: Product Launch
Launched China's first 5-minute on-site nucleic acid detection products with lab-grade accuracy.
Late 2024: High-Speed Rail Alliance
Partnered with China High-Speed Rail to provide exclusive rapid testing for pet transport safety.
2025: Digital Vet Ecosystem
Partnered with JD Health & New Ruipeng to build a closed-loop home-to-clinic service ecosystem.
2026: Future Expansion
Plan to launch early tumor and cardiovascular gene screening products for chronic disease care.
From rigorous R&D to market leadership. Trace our path in redefining molecular diagnostics.
March 2020: R&D Inception
Total Supply Chain Control: From Raw Materials to Devices
Total Supply Chain Control: From Raw Materials to Devices
Manufacturing Strength
Unlike assemblers, Changqi Biotech produces its own core enzymes, reagents, and instruments. This vertical integration ensures maximum cost efficiency, supply stability, and consistent quality for our global partners.
In-House Raw Materials:
Proprietary synthesis of core enzymes and reagents.
Automated Assembly:
High-volume automated lines for chips and devices.
Strict Quality Control:
Rigorous testing protocols at every production stage.
Cost Advantage:
Direct-from-factory pricing with no middleman markups.